Abstract 1587: <i>In Vivo</i> CRISPR screen of dendritic cells identifies Traf2 as a critical regulator of anti-tumor immunity via modulation of non-canonical NF-kB pathway
Chang Moon(Icahn School of Medicine at Mount Sinai), Miriam Merad(Icahn School of Medicine at Mount Sinai), Alexander Tepper(Broad Institute), S. Chen(Icahn School of Medicine at Mount Sinai), Meriem Belabed(Icahn School of Medicine at Mount Sinai), Camillia S. Azimi(Icahn School of Medicine at Mount Sinai), Alessandra Gurtner(Icahn School of Medicine at Mount Sinai), Adam Marks(Icahn School of Medicine at Mount Sinai), Brian Brown(Icahn School of Medicine at Mount Sinai), Natalie Vaninov(Icahn School of Medicine at Mount Sinai), Jessica Le Berichel(Icahn School of Medicine at Mount Sinai), Prerna Suri(Icahn School of Medicine at Mount Sinai), Matthew D. Park(Icahn School of Medicine at Mount Sinai), Alessia Baccarini(Icahn School of Medicine at Mount Sinai)
Cited by 0
Related Papers
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
|Science Translational Medicine|2021|257
Dendritic cell maturation in cancer
|Nature reviews. Cancer|2025|134